Traynor Capital Management’s AIM ImmunoTech AIM Stock Holding History

Traynor Capital Management’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-118	Closed	-$1.44K	–	315
2025 Q1	$1.44K	Hold	118	–	–	﹤0.01%	262
2024 Q4	$2.33K	Hold	118	–	–	﹤0.01%	293
2024 Q3	$3.18K	Hold	118	–	–	﹤0.01%	282
2024 Q2	$4.39K	Hold	118	–	–	﹤0.01%	283
2024 Q1	$5.55K	Hold	118	–	–	﹤0.01%	276
2023 Q4	$5.18K	Hold	118	–	–	﹤0.01%	243
2023 Q3	$5.36K	Hold	118	–	–	﹤0.01%	223
2023 Q2	$7.89K	Hold	118	–	–	﹤0.01%	217
2023 Q1	$5.06K	Hold	118	–	–	﹤0.01%	213
2022 Q4	$3.67K	Hold	118	–	–	﹤0.01%	219
2022 Q3	$6K	Hold	118	–	–	﹤0.01%	180
2022 Q2	$9K	Hold	118	–	–	﹤0.01%	175
2022 Q1	$12K	Hold	118	–	–	﹤0.01%	199
2021 Q4	$10K	Hold	118	–	–	﹤0.01%	221
2021 Q3	$23K	Hold	118	–	–	﹤0.01%	197
2021 Q2	$24K	Hold	118	–	–	﹤0.01%	184
2021 Q1	$26K	Sell	118 -30	-20%	-$6.77K	﹤0.01%	180
2020 Q4	$26K	Hold	148	–	–	﹤0.01%	157
2020 Q3	$31K	Buy	148 +30	+25%	+$7.49K	0.01%	149
2020 Q2	$29K	Hold	118	–	–	0.01%	150
2020 Q1	$30K	Buy	+118	New	+$18.5K	0.01%	128
2016 Q3	–	Hold	0	–	-$3K	–	141
2016 Q2	–	Hold	0	–	–	–	127
2016 Q1	–	Hold	0	–	–	–	118

Other funds holding AIM

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Traynor Capital Management's AIM Position: Q2 2025 in Review

Traynor Capital Management sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 118 shares — an estimated $1.44K sold.

Traynor Capital Management first reported a position in AIM in Q1 2020 and held it in 21 quarters. The position peaked at $31K in Q3 2020. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

Traynor Capital Management reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
Traynor Capital Management sold 118 AIM ImmunoTech shares in Q2 2025, an estimated $1.44K.
Traynor Capital Management first reported a position in AIM ImmunoTech in Q1 2020 and held it in 21 quarters.
Traynor Capital Management's AIM ImmunoTech position peaked at $31K in Q3 2020.
12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on Traynor Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.